1 6 bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes
Báo cáo y học: "Efficiency of vibration exercise for glycemic control in type 2 diabetes patients."
Ngày tải lên :
26/10/2012, 10:04
... Plasma [glucose] pretraining (mg / 10 0 ml) 12 0 ± 25 12 6 ± 23 13 3 ± 57 Plasma [glucose] posttraining (mg / 10 0 ml) 11 5 ± 22 12 0 ± 22 12 2 ± 35 Significance n.s n.s n.s HbA1C At baseline the HbA1c amounted ... SD Intervention group (number of subjects) Age (years) Weight (kp) Height (cm) Stretching (13 ) Strength (13 ) 63 ,3 ± 5,9 62 ,9 ± 7,3 62 ,2 ± 4,0 88 ,6 ± 24 ,1 86, 5 ± 14 ,7 83,3 ± 13 ,4 17 3 ± 14 ,2 17 2 ... 17 3 ± 14 ,2 17 2 ± 6, 7 17 7 ± 7 ,2 Vibration (14 ) Systolic blood pressure (mm Hg) 13 6 ± 13 ,8 14 2 ± 16 ,2 13 7 ± 15 ,1 Diastolic blood pressure (mm Hg) 83 ± 7,0 87 ± 10 ,4 79 ± 7,3 Figure 1: Images of the...
- 5
- 544
- 0
Báo cáo khoa học: Insulin resistance in human adipocytes occurs downstream of IRS1 after surgical cell isolation but at the 1 level of phosphorylation of IRS1 in type 2 diabetes pot
Ngày tải lên :
07/03/2014, 16:20
... 1. 1 1. 8 0 .6 0.7 0.9 1. 1 0 .1 0 .2 1. 1 1. 8 0 .6 0.7 0.3–0.4 0. 02 0.03 1. 1 1. 8 1. 8 2. 0 0 .6 0.7 0 .1 0 .2 1. 1 1. 8 1. 8 2. 0 0 .6 0.7 0 .1 0 .2 1. 1 1. 8 1. 8 2. 0 0 .6 0.7 0 .1 0 .2 1. 1 1. 8 1. 8 2. 0 0 .6 0.7 0 .1 0 .2 ... kinase pathway J Biol Chem 2 76, 454 56 454 61 33 Deibert DC & DeFronzo RA (19 80) Epinephrine-induced insulin resistance in man J Clin Inv 65 , 717 –7 21 34 Rizza RA, Mandarino LJ & Gerich JE (19 82) ... were incubated in Krebs ⁄ Ringer solution (0 . 12 m NaCl, 4.7 mm KCl, 2. 5 mm CaCl2, 1. 2 mm MgSO4, 1. 2 mm KH2PO4) containing 20 mm Hepes, pH 7.40, 1% (w ⁄ v) fatty acid-free bovine serum albumin, 10 0...
- 11
- 472
- 0
Tài liệu Báo cáo khoa học: Metabolic control of mitochondrial properties by adenine nucleotide translocator determines palmitoyl-CoA effects Implications for a mechanism linking obesity and type 2 diabetes pdf
Ngày tải lên :
19/02/2014, 05:20
... 0.040. 01 0 .15 0.05* 0 .24 0. 02* * 0. 26 0 . 02 0 .14 0. 02* 0 .14 0. 01 0 .14 0. 01* * 0 .22 0. 02 0 .20 0. 01* 0 .15 0. 01 0 .27 0.04 0 .15 0. 02 ) 0.030.00 0. 310 .04 0 .14 0. 01 0 . 16 0.04 0 . 16 0. 02* 0 . 16 0. 02 ) 0. 060 . 01* * 0 .28 0.03 0. 26 0 . 01* * ... 0.390. 02 ) 0. 810 .19 0 .18 0 .10 0.790. 31 ) 0 .11 0.05 0.790 .13 * ) 0.780 .11 * ) 0.880 .20 0 .25 0.05 0.850.03 ) 0.050. 01 0 .11 0. 01 0 .24 0.05 ) 1. 410 .04 0 .14 0.04* 0. 460 . 06* ) 0. 060 . 01 0 .23 0.07* 0.370.03* ) 1. 130. 01* ... 0.400 .10 0. 020 . 01 0.000.00 0.000.00 0.000. 01 0. 060 . 01 0.000.00 0.080. 01 0.330 .11 ) 0. 010 .03 ) 0. 010 .00 0.090 .27 3.7 91. 44 0.090. 01 4 .2 81. 68 0 .25 0.07 0. 020 .08 ) 0. 010 .00 0.050 .18 ) 1. 100 .18 0 . 16 0.01...
- 15
- 546
- 0
Effectiveness of PRECEDE model for health education on changes and level of control of HbA1c, blood pressure, lipids, and body mass index in patients with type 2 diabetes mellitus docx
Ngày tải lên :
05/03/2014, 22:21
... inhibitors Insulin 14 .2 (10 .4 -18 ) 14 .4 (10 .4 -18 .4) 0.94 Diuretics 27 .4 (22 .5- 32. 3) 23 .1 (18 .3 -27 .9) 0 .23 Beta blockers 12 .9 (9 .2 - 16 .6) 9.7 (6. 4 -13 .1) 0 .22 ACE inhibitors 30 .6 (25 .5-35.7) 29 .1 ... (24 -34 .2) 0 .68 ARB 14 .5 (10 .6 -18 .4) 12 .4 (8.7 - 16 .1) 0.47 Hypolipidemic 35.3 (30 .1- 40 .6) 30.4 (25 .2- 35 .6) 0 .2 Calcium antagonist Antiplatelet 15 .1% (11 .2 -19 ) 22 .4 (17 .8 -27 ) 19 .1 (14 .7 -23 .6) 17 .7 ... value -7 .25 (30) 0 .1 -7 .27 (28 ) 0 .11 0. 02 (-4 .6 to 4.7) 0.99 -2 .64 ( -6. 9 to 1. 6) 0 .22 Basal 51 (14 ) 47 (11 ) Final 52 (14 ) 51 (14 ) Change 0.8 (13 ) p value
- 9
- 654
- 1
TYPE 2 DIABETES - National clinical guideline for management in primary and secondary care (update) pdf
Ngày tải lên :
08/03/2014, 14:20
... combination therapy with insulin Insulin therapy Insulin detemir Insulin delivery devices 12 5 13 0 14 6 14 6 12 12 .1 12. 2 12 .3 Blood pressure therapy Clinical introduction Blood pressure lowering ... Exenatide: GLP -1 mimetics 11 4 Oral glucose control therapies (2) : other oral agents and exenatide; 12 0 from evidence to recommendations 11 11 .1 11. 2 11 .3 11 .4 Glucose control: insulin therapy Oral ... and intervention levels Blood pressure lowering medications 15 1 15 1 15 7 Cardiovascular risk estimation 18 1 14 14 .1 14 .2 14 .3 14 .4 14 .5 14 .6 Management of blood lipid levels Overall clinical introduction...
- 278
- 1.3K
- 0
báo cáo hóa học:" Determinants of quality of life in adults with type 1 and type 2 diabetes" pdf
Ngày tải lên :
20/06/2014, 15:20
... factors Diabetes duration (years) Insulin use Yes Number of comorbidities (range 0-5) < 0.00 01 490 (10 0.0) 25 4 (22 .1) 1. 1 (1. 2) 1. 6 (1. 2) < 0.00 01 199 (40 .6) 22 0 (19 .2) 13 8 (28 .2) 329 (28 .7) 85 (17 .3) ... (34.9) < $20 ,000 50 (10 .2) 15 7 (13 .7) $20 ,000-39,999 11 2 (22 .9) 330 (28 .8) $40,000-59,999 $60 ,000-79,999 10 5 ( 21 . 4) 10 9 (22 .2) 29 3 (25 .5) 17 2 (15 .0) Marital status 0.03 0 .11 No partner Have partner ... 0.0 01 Annual income < 0.00 01 $80,000-99,999 43 (8.8) 89 (7.8) $10 0,000 < 71 (14 .5) 10 6 (9 .2) Activity (personality) trait (score 1- 5) 3.3 (0 .6) 3 .2 (0 .6) 0 .11 21 . 6 ( 12 .8) 11 .2 ( 12 .8) < 0.00 01 Medical...
- 9
- 500
- 0
Nghiên cứu khoa học nông nghiệp " A blueprint for sustainable small holder pig production in Central Vietnam " pdf
Ngày tải lên :
21/06/2014, 06:20
... depart 15 :00 / arrive 16 :20 12 th November Hue Confined to hotel due to flooding 13 th November Hue 14 th November Hue Meetings with Professor Linh, Dr Duyet, Mr Toan, and Mr Phuong Re: schedule for ... the market chain and slaughter houses 20 th November Hue Hue to Ha Noi: depart 12 :10 / arrive 13 :20 21 st November Ha Noi Meeting at NIVR with project leaders 22 nd November Ha Noi 23 rd November ... National Centre for Veterinary Diagnosis Meeting with World Vision re Indonesian Projects 24 th – 25 th Nov Ha Noi Free 26 th Nov Ha Noi Meetings with CIP Farmer Training Program Co-ordinators 27 th November...
- 8
- 411
- 1
Nghiên cứu khoa học nông nghiệp " A blueprint for sustainable small holder pig production in Central Vietnam " potx
Ngày tải lên :
21/06/2014, 06:20
... lab was going to be used for testing faeces for E.coli vaccine trial • Blood bank refrigerator • Biomedical freezer • ‘Binder’ – cabinets (incubators?) • x Microscopes, Olympus, TH4 -20 0 • Purifier ... audits being conducted during my time in Vietnam E coli vaccination project Thuy Duong commune: Farm Age of piglets (days) 28 Diarrhoea Vaccination status N Y Samples collected Y Y 28 Y Y N N ... • Project farms visited in both 20 09 and 2 010 had made very good progress and appeared to be producing good quality pigs • There were some new control farms due to the production of the DVD •...
- 3
- 294
- 0
Nghiên cứu khoa học nông nghiệp " A blueprint for sustainable small holder pig production in Central Vietnam " ppt
Ngày tải lên :
21/06/2014, 06:20
... 12 :05 / arrive 17 :40 20 th May Ha Noi Singapore to Ha Noi: depart 10 :05 / arrive 12 :20 21 st May Hue 22 nd May Hue 23 rd May Hue 24 th May Hue 25 th May Hue 26 th May Hue 27 th May Hue 28 th May Hue 29 th ... depart 10 :10 / arrive 11 :20 Meeting with colleagues from Hue Meetings at HUAF to prepare for Farmer Training program while waiting for Team members from NIVR and NIAH to arrive Visit Phai Dinh Quy ... Province Visit Nguyen Huu Kiem Farm in Thua Thien Hue Province Training Review Meeting – HUAF Campus Project Review and Planning Meeting – HUAF Campus Hue to Ha Noi: depart 12 :10 / arrive 13 :20 ...
- 32
- 296
- 0
Báo cáo nghiên cứu khoa học " SOME TECHNICAL SOLUTIONS SUITABLE FOR DEVELOPMENT OF SMALLHOLDER PIG PRODUCTION IN QUANG TRI AND THUA THIEN - HUE PROVINCES " doc
Ngày tải lên :
22/06/2014, 12:20
... 11 .10 a 10 .73 a 6. 23 a 10 .17 a a 1. 22 19 3 1. 77 19 3 1. 60 19 3 0.94 19 3 1. 32 19 3 SD X 11 .43 a 2. 47 11 .09 a 2. 50 6. 70 a 1. 74 10 .97 b 2. 22 10 . 81 b 2 .11 Number of piglets weaned/ litter (piglet) 12 8 ... 12 10 .47 ± 1. 53 11 . 12 ± 2. 57 The number of piglets weaned /litter 12 8 .2 ± 2 . 16 a 9 .25 ± 1. 22 b Weight gain per day (g/day) 12 10 7 ± 15 .42a 12 6. 25 ± 19 .50b Disease infected (n) 12 2. 53 ± 1. 33 1. 33 ... (n = 10 ) μ ± SE 24 .7 ± 0. 51 27 .5 ± 0 . 12 25 .6 ± 0 .11 92. 0 ± 0 .13 83.9 ± 0 .24 89.0 ± 0 .15 27 .3 ± 0 .18 35 .1 ± 1. 37 29 .9 ± 0 .23 Experiment (n = 10 ) μ ± SE 26 . 0 ± 0 .14 28 .4 ± 0 .14 26 . 8 ± 0 . 12 88.5...
- 10
- 513
- 2
Báo cáo y học: "Threshold for detection of diabetic peripheral sensory neuropathy using a range of research grade monofilaments in persons with Type 2 diabetes mellitu" pot
Ngày tải lên :
10/08/2014, 21:23
... = 91 Comparison n = 73 p value 44 36 59 .6 8.4 17 0.7 9 .1 94.8 17 32. 7** 6 .1 1.4 14 1 17 .2 82. 7** 7.9 12 .5 7.4 66 25 61 . 4 8.4 17 1.4 8.7 89 .2 16 30.5** 5.5 8.3 1. 6 13 6 18 .3 76. 9** 9.5 10 6. 3 78 .2 38 ... Excellence, London; 20 04 Page of (page number not for citation purposes) Journal of Foot and Ankle Research 20 08, 1: 9 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Frykberg RG, Lavery ... 76. 9** 9.5 10 6. 3 78 .2 38 35 52 .6* 10 .6 17 2 .6 9.5 76. 6* 1. 6 25 .5* 3.4 5 .6* 0.5 12 9* 17 .2 79.5 11 .8 N/A = 0. 013 *
- 7
- 309
- 0
báo cáo khoa học:" Determinants of quality of life in adults with type 1 and type 2 diabetes" ppsx
Ngày tải lên :
11/08/2014, 23:22
... Yes 490 (10 0.0) 25 4 (22 .1) Number of comorbidities 1. 1 (1. 2) 1. 6 (1. 2) < 0.00 01 (range 0-5) 19 9 (40 .6) 22 0 (19 .2) 13 8 (28 .2) 329 (28 .7) 85 (17 .3) 377 ( 32. 9) 44 (9.0) 14 7 ( 12 .8) 20 (4 .1) 62 (5.4) ... 0. 26 -0 .24 -0 .20 -0 .11 0 .13 Sig 0.00 01 0. 01 0. 02
- 34
- 254
- 0
Báo cáo y học: "Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetes" ppsx
Ngày tải lên :
14/08/2014, 07:21
... liquid infused t = 30 to 27 0 at kcal/min IV GLP -1 (1. 2pmol/kg/min) or placebo infused t = to 27 0min 35 30 25 Insulin 20 GLP -1 (mU/L) Placebo 15 10 0 30 60 90 12 0 15 0 18 0 21 0 24 0 27 0 Time (minutes) ... GLP -1 administration, including baseline (at t = minutes: GLP -1: 18 1 ± 24 vs placebo: 21 9 ± 29 pmol/l; P = 0. 06, at t = 30 minutes: GLP -1: 17 5 ± 21 vs placebo: 21 4 ± 29 : P = 0. 06, and at t = 27 0 ... http://ccforum.com/content /15 /1/ R35 0*^+ 15 30*^+ 45*^ 60 *^+ Page of 11 90*^+ 12 0*^+ 15 0*^+ 18 0 21 0 *^+ 24 0 27 0^+ Time (minutes) IV GLP -1 (1. 2pmol/kg/min) or placebo infused t = to 27 0mins Post...
- 11
- 338
- 0
Báo cáo y học: "Mediators of physical activity change in a behavioral modification program for type 2 diabetes patients" docx
Ngày tải lên :
14/08/2014, 08:20
... t 23 31. 57 (69 8.80) 36. 24 (33. 52) 14 6. 75 (70. 91) 40. 21 (33.07) 2 26 . 30 (69 . 31) 0 01 28 3 0 42 228 0 02 16 0. 41 15 .27 44.03 15 . 41 57 . 16 1. 07 2. 37* 2. 54* 2 . 16 * 4.07* 29 .5% Proportion mediated 23 .1% 27 .7% ... total PA PA τ (SE) 24 91. 98 ( 61 7 .29 ) 51. 41 (28 . 61 ) 19 0.78 ( 61 . 62 ) 55 . 62 (29 .08) 28 3. 46 ( 62 . 76) p < 0 01 0 76 003 059
- 13
- 276
- 0
IMPAIRED CARDIOVASCULAR RESPONSES TO GLUCAGON-LIKE PEPTIDE 1 IN METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITUS
Ngày tải lên :
24/08/2014, 12:16
... antibodies against cardiac troponin I (ab1 02 31; 1: 1,000), 4’,6diamidino -2- phenylindole (DAPI; 10 0 ng/ml), and rabbit polyclonal antibodies raised against GLP-1R (ab390 72; 1: 25 ) for one hour Slices ... performance (89, 93, 10 2) GLP -1 and Myocardial Glucose Uptake Increasing myocardial glucose uptake has been a target for cardioprotection for decades ( 52, 57, 11 2 -11 7) Some of the theory behind ... factors (11 , 13 , 14 , 17 -20 , 22 , 26 , 27 , 29 , 33, 40, 43, 53 56) Just as systemic glucose metabolism is impaired in this population, cardiac glucose metabolism is also impaired, and treatments that increase...
- 128
- 188
- 0
Metformin an old but still the best treatment for type 2 diabetes
Ngày tải lên :
12/07/2015, 15:49
... 10 6 10 7 10 8 10 9 11 0 11 1 11 2 11 3 11 4 11 5 11 6 11 7 nondiabetic subjects: the BIGPRO1 Study Biguanides and the Prevention of the Risk of Obesity Diabetes Care 19 98, 21 : 1 967 19 72 Wu RR, Zhao JP, Jin ... 11 12 13 14 15 16 17 18 19 20 21 22 23 Shaw RJ, Lamia KA, Vasquez D, et al: The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin Science 20 05, 310 : 16 42 16 46 ... BMJ 2 010 , 340:c 21 8 1 Page 15 of 15 16 9 Wei Ting RZ, Szeto CC, Chan M, Ma K, et al: Risk Factors of Vitamin B 12 Deficiency in Patients Receiving Metformin Arch Intern Med 20 06, 16 6 :19 75 19 79 17 0...
- 15
- 664
- 0
Aspects of carbohydrate quality and their relevance for risk markers of type 2 diabetes and related health outcomes
Ngày tải lên :
25/11/2015, 14:52
... insulin index, glycemic index, and glycemic load during puberty with body composition in young adulthood International Journal of Obesity (London) (2 0 12 ) 36, 14 63 -14 71 doi: 10 .10 38/ijo .2 011 .2 41 ... dietary insulin index during puberty and body composition in young adulthood o International Journal of Obesity Supplements (2 011 ) 1: S 16 o Proceedings of the German Nutrition Society (2 011 ) 15 : 10 ... (OGTT) Diabetes mellitus: Fasting plasma glucose ≥ 12 6 mg/dl (≥ 7.0 mmol/L) or 2- h plasma glucose* ≥ 20 0 mg/dl ( 11 .1 mmol/L) Impaired fasting glucose (IFG): Fasting plasma glucose 11 0 mg/dl...
- 203
- 431
- 0
Model based controllers for blood glucose regulation in type i diabetics
Ngày tải lên :
26/11/2015, 12:30
... 21 . 43 25 ΓKE (2 . 16 ) = 71 + 71 tanh[0. 011 (G CK − 460 )], for G CK < 460 = 0.872G CK − 330, for G CK ≥ 460 ΓPGU = (2 .15 ) IT 35G TP [7.035 + 6. 5 16 23 tanh{0.33 827 ( P − 5.8 21 1 3)}] 5.304 86. 81 (2 .17 ) ... =43.7 L/min v =11 .2 dL q S =10 .1 L/min v CL =25 .1 dL q L = 12 .6 L/min q A =2. 5 L/min C K C P T P C B C H C S v =6. 6 dL q K =10 .1 L/min v =10 .4 dL q P =15 .1 L/min TPG =5.0 v =63 .0 L V =0. 26 5 L Q ... = 70 (2. 9) ΓRBCU = 10 (2 .10 ) ΓSU = 20 (2 .11 ) 18 Chapter 2: Physiological Modeling of Diabetic ΓHGP = 15 5AIHGP [2. 7 tanh(0.388N) − ANHGP] [1. 425 1. 406tanh{0. 61 9 9( GCL − 0.4 969 )}] (2 . 12 ) 10 1 ⎤ I CL...
- 111
- 361
- 0
Global Guideline for Type 2 Diabetes
Ngày tải lên :
18/06/2016, 11:42
... 10 11 12 13 14 15 16 17 Association 20 03 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada Canadian Journal of Diabetes 20 03; 27 (Suppl 2) : S50S 52 http://www .diabetes. ca ... sulfonylurea, metformin, or insulin in patients with type diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) JAMA 19 99; 2 81: 20 05 - 12 Global Guideline for Type Diabetes 11 Goldhaber-Fiebert ... Screening and diagnosis 02 Care delivery 12 03 Education 16 04 Psychological care 19 05 Lifestyle management 22 06 Glucose control levels 26 07 Clinical monitoring 29 08 Self-monitoring 32 09 Glucose...
- 82
- 218
- 0
Báo cáo khoa học: Complexes of Thermoactinomyces vulgaris R-47 a-amylase 1 and pullulan model oligossacharides provide new insight into the mechanism for recognizing substrates with a-(1,6) glycosidic linkages docx
Ngày tải lên :
16/03/2014, 14:20
... Molecules in asymmetric unit (n) 10 0 2. 08 13 7 329 10 0 2 .1 98 12 4 10 0 2 .6 59, 023 38 4 46 99.8 0. 063 (0 .14 9)b 17 .4 ( 12 .9)b C2 28 14 0 99.9 0. 064 (0 .19 5)b 9.7 (3 .6) b P 21 19 ,27 5 96. 8 0.078 (0 . 12 2) b 7.4 ... (0 .25 4)a 0.0 06 1. 3 35 2 .6 19 ,27 5 96. 7 (84 .1) a 0 .15 0 (0 .18 3)a 0 .19 0 (0. 26 4 )a 0.0 06 1. 3 5038 12 5 4 52 5038 78 383 5038 22 5 474 11 .9 42. 3 21 . 5 16 .4 37.7 25 .6 13 .9 54.5 19 .4 ˚ ˚ The values for the highest ... in parentheses (2. 21 2. 08 A for D356N/P2, 2. 23 2 .10 A for D356N/E396Q/P2, and ˚ 2. 76 2 .60 A for D356N/E396Q/P5) a Overall structures TVAI is comprised of four domains; domain N (residues 1 12 3)...
- 9
- 342
- 0